Psychiatric manifestations of rheumatic diseases
DOI:
https://doi.org/10.12775/JEHS.2022.12.08.005Keywords
rheumatic diseases, psychiatric symptoms, depressionAbstract
Introduction and purpose of the work: Rheumatic diseases are chronic diseases that cause symptoms in many systems of the human body. Their most common symptoms include pain and symptoms of arthritis, their deformities, fatigue, and malaise. The aim of the article is to present the symptoms and mental disorders occurring in the course of selected rheumatic diseases.
State of knowledge: The psychological symptoms are characteristic of systemic lupus erythematosus. Specified is a form of lupus called NSPLE (neuropsychiatric systemic lupus erythematosus), which includes neuropsychiatric symptoms in the course of systemic lupus erythematosus. Psychiatric symptoms are also present in the course of other rheumatic diseases. Neuropsychiatric symptoms may affect up to 80% of patients with primary Sjogren's syndrome, with 50% to 80% ahead of diagnosis. It has been proven that systemic slcerosis causes microvascular damage, which may cause neuropsychiatric symptoms in the form of mood disorders, anxiety and cognitive disorders. In one study, 59% of patients with fibromyalgia experienced mania, which was more than twice as high as in the control group.
Summary: In the course of all rheumatic diseases presented by us, there are symptoms and mental disorders. They are often mood, cognitive and sleep disturbances. It should be emphasized that the etiology of psychiatric symptoms is multifactorial.
References
10 things you should know about rheumatic diseases n / a: https: //www.eular.org/myUploadData/files/10%20thin. www.eular.org (accessed May 29, 2022).
Jeppesen R, Benros ME. Autoimmune Diseases and Psychotic Disorders. Front Psychiatry 2019; 10: 131. https://doi.org/10.3389/FPSYT.2019.00131.
Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, et al. 2019 European League Against Rheumatism / American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis 2019; 78: 1151–9. https://doi.org/10.1136/annrheumdis-2018-214819.
Meszaros ZS, Perl A, Faraone S V. Psychiatric symptoms in systemic lupus erythematosus: a systematic review. J Clin Psychiatry 2012; 73: 993–1013. https://doi.org/10.4088/JCP.11R07425.
Fanouriakis A, Bertsias G, Govoni M. Editorial: Lupus and the Brain: Advances in Neuropsychiatric Systemic Lupus Erythematosus. Front Med 2019; 6. https://doi.org/10.3389/FMED.2019.00052.
Kozora E, Thompson LL, West SG, Kotzin BL. Analysis of cognitive and psychological deficits in systemic lupus erythematosus patients without overt central nervous system disease. Arthritis Rheum 1996; 39: 2035–45. https://doi.org/10.1002/ART.1780391213.
Huerta PT, Gibson EL, Rey C, Huerta TS. Integrative neuroscience approach to neuropsychiatric lupus. Immunol Res 2015; 63: 11–7. https://doi.org/10.1007/S12026-015-8713-6.
Sergent JS, Lockshin MD, Klempner MS, Lipsky BA. Central nervous system disease in systemic lupus erythematosus: Therapy and prognosis. Am J Med 1975; 58: 644–54. https://doi.org/10.1016/0002-9343(75)90500-8.
Chau SY, Mok CC. Factors predictive of corticosteroid psychosis in patients with systemic lupus erythematosus. Neurology 2003; 61: 104–7. https://doi.org/10.1212/WNL.61.1.104.
Fernandez H, Cevallos A, Jimbo Sotomayor R, Naranjo-Saltos F, Mera Orces D, Basantes E. Mental disorders in systemic lupus erythematosus: a cohort study. Rheumatol Int 2019; 39: 1689–95. https://doi.org/10.1007/S00296-019-04423-4.
Pego-reigosa JM, Isenberg DA. Psychosis due to systemic lupus erythematosus: characteristics and long-term outcome of this rare manifestation of the disease. Rheumatology (Oxford) 2008; 47: 1498–502.https://doi.org/10.1093/RHEUMATOLOGY/KEN260.
Fujieda Y. Diversity of neuropsychiatric manifestations in systemic lupus erythematosus. Immunol Med 2020; 43: 135–41. https://doi.org/10.1080/25785826.2020.1770947.
Hsieh MC, Hsu CW, Lu MC, Koo M. Increased risks of psychiatric disorders in patients with primary Sjögren's syndrome-a secondary cohort analysis of nationwide, population-based health claim data. Clin Rheumatol 2019; 38: 3195–203. https://doi.org/10.1007/S10067-019-04705-Z.
Wang LY, Chiang JH, Chen SF, Shen YC. Systemic autoimmune diseases are associated with an increased risk of bipolar disorder: A nationwide population-based cohort study. J Affect Disord 2018; 227: 31–7. https://doi.org/10.1016/J.JAD.2017.10.027.
Eaton WW, Byrne M, Ewald H, Mors O, Chen CY, Agerbo E, et al. Association of schizophrenia and autoimmune diseases: Linkage of Danish national registers. Am J Psychiatry 2006; 163: 521–8. https://doi.org/10.1176/APPI.AJP.163.3.521/ASSET/IMAGES/LARGE/Q228T4.JPEG.
Ravan JR, Chatterjee S, Singh P, Maikap D, Padhan P. Autoimmune Rheumatic Diseases Masquerading as Psychiatric Disorders: A Case Series. Mediterr J Rheumatol 2021; 32: 164. https://doi.org/10.31138/MJR.32.2.164.
Manzo C, Martinez-Suarez E, Kechida M, Isetta M, Serra-Mestres J. Cognitive Function in Primary Sjögren's Syndrome: A Systematic Review. Brain Sci 2019; 9. https://doi.org/10.3390/BRAINSCI9040085.
Morreale M, Francia A, Marchione P, Manuppella F, Giacomini P. Intracranial hemodynamic changes in primary Sjögren syndrome: a transcranial Doppler case-control study. Neurol Sci 2015; 36: 1589–95. https://doi.org/10.1007/S10072-015-2204-3.
Tezcan ME, Kocer EB, Haznedaroglu S, Sonmez C, Mercan R, Yucel AA, et al. Primary Sjögren's syndrome is associated with significant cognitive dysfunction. Int J Rheum Dis 2016; 19: 981–8. https://doi.org/10.1111/1756-185X.12912.
Wang Y, Wang SL, Zou YZ LG. Psychiatric and central nervous system involvement in Sjogren's syndrome. Zhonghua Kou Qiang Yi Xue Za Zhi 2004; 39 (2): 158-: 158-60.
Hammett EK, Fernandez-Carbonell C, Crayne C, Boneparth A, Cron RQ, Radhakrishna SM. Adolescent Sjogren's syndrome presenting as psychosis: a case series. Pediatrician Rheumatol Online J 2020; 18. https://doi.org/10.1186/S12969-020-0412-8.
Wong JKF, Nortley R, Andrews T, D'Cruz D. Psychiatric manifestations of primary Sjögren's syndrome: a case report and literature review. BMJ Case Rep 2014; 2014. https://doi.org/10.1136/BCR-2012-008038.
Marrie RA, Hitchon CA, Walld R, Patten SB, Bolton JM, Sareen J, et al. Increased Burden of Psychiatric Disorders in Rheumatoid Arthritis. Arthritis Care Res 2018; 70: 970–8. https://doi.org/10.1002/ACR.23539/ABSTRACT.
Jeppesen R, Benros ME. Autoimmune diseases and psychotic disorders. Front Psychiatry 2019; 10: 131. https://doi.org/10.3389/FPSYT.2019.00131/BIBTEX.
Eaton WW, Byrne M, Ewald H, Mors O, Chen CY, Agerbo E, et al. Association of schizophrenia and autoimmune diseases: linkage of Danish national registers. Am J Psychiatry 2006; 163: 521–8. https://doi.org/10.1176/APPI.AJP.163.3.521.
Cullen AE, Holmes S, Pollak TA, Blackman G, Joyce DW, Kempton MJ, et al. Associations Between Non-neurological Autoimmune Disorders and Psychosis: A Meta-analysis. Biol Psychiatry 2019; 85: 35–48. https://doi.org/10.1016/J.BIOPSYCH.2018.06.016.
Sellgren C, Frisell T, Lichtenstein P, Landen M, Askling J. The association between schizophrenia and rheumatoid arthritis: a nationwide population-based Swedish study on intraindividual and familial risks. Schizophr Bull 2014; 40: 1552–9. https://doi.org/10.1093/SCHBUL/SBU054.
McNair S, Hategan A, Bourgeois JA, Losier B. Neuropsychiatric symptoms in scleroderma. Psychosomatics 2013; 54: 382–6. https://doi.org/10.1016/J.PSYM.2012.09.002.
GM, Bhat KM, AP, GL, MG C. Psychiatric Symptoms and Quality of Life in Systemic Sclerosis. Clin Pract Epidemiol Ment Health 2012; 8:30. https://doi.org/10.2174/1745017901208010030.
Danieli E, Airò P, Bettoni L, Cinquini M, Antonioli CM, Cavazzana I, et al. Health-related quality of life measured by the Short Form 36 (SF-36) in systemic sclerosis: correlations with indexes of disease activity and severity, disability, and depressive symptoms. Clin Rheumatol 2005; 24: 48–54. https://doi.org/10.1007/S10067-004-0970-Z.
Mozzetta A, Antinone V, Alfani S, Neri P, Bonda PGF, Pasquini P, et al. Mental health in patients with systemic sclerosis: a controlled investigation. J Eur Acad Dermatol Venereol 2008; 22: 336–40. https://doi.org/10.1111/J.1468-3083.2007.02426.X.
Yilmaz N, Mollahasanoglu A, Gurvit H, Can M, Tuncer N, Ananc N, et al. Dysexecutive syndrome: A specific pattern of cognitive impairment in systemic sclerosis. Cogn Behav Neurol 2012; 25: 57–62. https://doi.org/10.1097/WNN.0B013E3182593C75.
Angelopoulos N V., Drosos AA, Moutsopoulos HM. Psychiatric symptoms associated with scleroderma. Psychother Psychosom 2001; 70: 145–50. https://doi.org/10.1159/000056240.
Clauw DJ. Fibromyalgia: a clinical review. JAMA 2014; 311: 1547–55. https://doi.org/10.1001/JAMA.2014.3266.
Alciati A, Sgiarovello P, Atzeni F, Sarzi-Puttini P. Psychiatric problems in fibromyalgia: clinical and neurobiological links between mood disorders and fibromyalgia. Reumatismo 2012; 64: 268–74. https://doi.org/10.4081/REUMATISMO.2012.268.
Carta MG, Cardia C, Mannu F, Intilla G, Hardoy MC, Anedda C, et al. The highfrequency of manic symptoms in fibromyalgia does influence the choice of treatment? Clin Pract Epidemiol Ment Health 2006; 2. https://doi.org/10.1186/1745-0179-2-36.
Dell'Osso L, Bazzichi L, Consoli G, Carmassi C, Carlini M, Massimetti E, Giacomelli C, Bombardieri S CA. A. Manic spectrum symptoms are correlated to the severity of pain and the health-related quality of life in patients with fibromyalgia. Clin Exp Rheumatol 2009; Sep-Oct; 27: 57–61.
Dreyer L, Kendall S, Danneskiold-Samsøe B, Bartels EM, Bliddal H. Mortality in a cohort of Danish patients with fibromyalgia: increased frequency of suicide. Arthritis Rheum 2010; 62: 3101–8. https://doi.org/10.1002/ART.27623.
Roizenblatt S, Neto NSR, Tufik S. Sleep disorders and fibromyalgia. Curr Pain Headache Rep 2011; 15: 347–57. https://doi.org/10.1007/S11916-011-0213-3.
Durmus D, Sarisoy G, Alayli G, Kesmen H, Çetin E, Bilgici A, et al. Psychiatric symptoms in ankylosing spondylitis: their relationship with disease activity, functional capacity, pain and fatigue. Compr Psychiatry 2015; 62: 170–7. https://doi.org/10.1016/J.COMPPSYCH.2015.07.016.
Mercadante MT, Busatto GF, Lombroso PJ, Prado L, Rosario-Campos MC, Do Valle R, et al. The psychiatric symptoms of rheumatic fever. Am J Psychiatry 2000; 157: 2036–8. https://doi.org/10.1176/APPI.AJP.157.12.2036.
de Alvarenga PG, Floresi AC, Torres AR, Hounie AG, Fossaluza V, Gentil AF, et al. Higher prevalence of obsessive-compulsive spectrum disorders in rheumatic fever. Gen Hosp Psychiatry 2009; 31: 178–80. https://doi.org/10.1016/J.GENHOSPPSYCH.2008.11.003.
Seixas AAA, Hounie AG, Fossaluza V, Curi M, Alvarenga PG, De Mathis MA, et al. Anxiety disorders and rheumatic Fever: is there an association? CNS Spectr 2008; 13: 1039–46. https://doi.org/10.1017/S1092852900017090.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Hubert Wróblewski, Dariusz Chojęta, Aleksandra Zimna, Ewelina Zygmunt, Anna Kozłowska, Monika Mierzwa, Kinga Wróblewska
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 832
Number of citations: 0
